![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 17, 2015 9:58:02 AM
SCIVAC connections: CLS therapeutics and Xenetic Biosciences
CLS therapeutics recently acquired a large number of shares of scivac. The agreement allows scivac to develop and commercialize a bunch of their patents and pre-clinical research. They have a great IP portfolio and looks promising. In addition, Russian OJSC Pharmsynthez and their management (including Dmitry Genkin- who also was involved with FDS pharma) owns a large part of CLS therapeutics as well as Xenetic Biosciences (XBIO). XBIO recently came out with positive data on their long acting EPO drug for CKD and other diseases. They also have a long acting oxyntomodulin (for diabetes).... Sound familiar? Thats because OPKO is working on drugs for long acting oxyntomodulin (acquired by OPKO during Prolor deal). Also OPKO is working on CKD drugs
OH THE CIRCLE OF CONNECTIONS.... check out these companies... they will all end up being acquired by OPKO within time... FROST is building an empire, glad i can be a part of it.
Recent VBIV News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:05:34 PM
- VBI Vaccines Provides an Update on its Restructuring Proceedings • Business Wire • 08/02/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 02:28:18 PM
- VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives • Business Wire • 07/30/2024 01:55:00 PM
- VBI Vaccines Announces Results of Annual General Meeting • Business Wire • 06/25/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 12:00:20 PM
- VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients • Business Wire • 05/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 09:00:33 PM
- VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients • Business Wire • 05/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:18:29 PM
- VBI Vaccines Reports First Quarter 2024 Financial Results • Business Wire • 05/15/2024 08:00:00 PM
- VBI Vaccines Reports Full Year 2023 Financial Results • Business Wire • 04/16/2024 12:00:00 PM
- VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • Business Wire • 04/11/2024 08:05:00 PM
- VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • Business Wire • 04/09/2024 06:45:00 PM
- VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma • Business Wire • 04/03/2024 12:00:00 PM
- VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform • Business Wire • 04/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 01:34:40 PM
- VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences • Business Wire • 02/14/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:23:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:15:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:15:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 01:00:27 PM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM